Total Payments
$243,434
2024 Payments
$36,742
Companies
31
Transactions
319
Medicare Patients
11,572
Medicare Billing
$6.2M
Payment Breakdown by Category
Other$185,586 (76.2%)
Consulting$35,799 (14.7%)
Travel$16,606 (6.8%)
Food & Beverage$5,428 (2.2%)
Education$14.96 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $156,609 | 64 | 64.3% |
| Consulting Fee | $35,799 | 29 | 14.7% |
| Honoraria | $28,975 | 17 | 11.9% |
| Travel and Lodging | $16,606 | 79 | 6.8% |
| Food and Beverage | $5,428 | 124 | 2.2% |
| Education | $14.96 | 1 | 0.0% |
| Current or prospective ownership or investment interest | $2.00 | 2 | 0.0% |
| Unspecified | $0 | 3 | 0.0% |
Payments by Type
General
$243,434
316 transactions
Ownership
$0
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $101,199 | 109 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $63,046 | 68 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $53,222 | 73 | $0 (2022) |
| Merck Sharp & Dohme LLC | $12,503 | 14 | $0 (2024) |
| Lilly USA, LLC | $11,648 | 10 | $0 (2017) |
| Elekta, Inc. | $367.86 | 4 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $333.35 | 5 | $0 (2024) |
| Telix Pharmaceuticals | $166.86 | 3 | $0 (2024) |
| Galvanize Therapeutics, Inc | $145.00 | 1 | $0 (2023) |
| Medtronic USA, Inc. | $125.01 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36,742 | 59 | Myriad Genetic Laboratories, Inc. ($27,980) |
| 2023 | $29,891 | 33 | Myriad Genetic Laboratories, Inc. ($19,301) |
| 2022 | $21,772 | 24 | Myriad Genetic Laboratories, Inc. ($15,765) |
| 2021 | $9,901 | 5 | Bayer HealthCare Pharmaceuticals Inc. ($9,886) |
| 2020 | $17,491 | 17 | Bayer HealthCare Pharmaceuticals Inc. ($17,490) |
| 2019 | $6,168 | 14 | Bayer HealthCare Pharmaceuticals Inc. ($5,779) |
| 2018 | $35,920 | 61 | Bayer HealthCare Pharmaceuticals Inc. ($26,757) |
| 2017 | $85,550 | 106 | E.R. Squibb & Sons, L.L.C. ($53,151) |
All Payment Transactions
319 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $62.25 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 12/10/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 12/04/2024 | Agios Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.66 | General |
| 11/23/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Consulting Fee | In-kind items and services | $3,025.00 | General |
| Category: ONCOLOGY | ||||||
| 11/23/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Consulting Fee | In-kind items and services | $2,475.00 | General |
| Category: ONCOLOGY | ||||||
| 11/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,446.00 | General |
| Category: Oncology | ||||||
| 11/23/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: ONCOLOGY | ||||||
| 11/23/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Travel and Lodging | In-kind items and services | $24.30 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Consulting Fee | In-kind items and services | $2,612.50 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Travel and Lodging | In-kind items and services | $35.88 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $22.39 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Consulting Fee | In-kind items and services | $2,200.00 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,423.00 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Travel and Lodging | In-kind items and services | $1,184.62 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), REBLOZYL, WELIREG | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Honoraria | In-kind items and services | $4,400.00 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Honoraria | In-kind items and services | $1,650.00 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 2,754 | 21,214 | $6.5M | $1.7M |
| 2022 | 36 | 2,867 | 24,736 | $6.0M | $1.6M |
| 2021 | 37 | 3,034 | 24,681 | $5.9M | $1.5M |
| 2020 | 37 | 2,917 | 24,426 | $5.6M | $1.4M |
Total Patients
11,572
Total Services
95,057
Medicare Billing
$6.2M
Procedure Codes
147
All Medicare Procedures & Services
147 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 283 | 322 | $1.3M | $378,913 | 30.2% |
| A9596 | Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | Office | 2023 | 71 | 430 | $1.2M | $355,311 | 29.3% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 116 | 868 | $1.1M | $253,520 | 24.0% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 74 | 83 | $510,284 | $122,991 | 24.1% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 132 | 990 | $445,100 | $96,502 | 21.7% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 266 | 315 | $200,970 | $87,001 | 43.3% |
| 78816 | Nuclear medicine study whole body with ct scan | Office | 2023 | 59 | 70 | $273,000 | $81,207 | 29.7% |
| 77373 | Cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 25 | 51 | $243,270 | $41,764 | 17.2% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 81 | 264 | $138,336 | $39,651 | 28.7% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 75 | 99 | $158,400 | $36,886 | 23.3% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 100 | 360 | $99,000 | $25,146 | 25.4% |
| G6012 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | Office | 2023 | 23 | 131 | $90,914 | $24,933 | 27.4% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 79 | 99 | $89,100 | $18,473 | 20.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 181 | 251 | $44,427 | $15,692 | 35.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 94 | 94 | $48,222 | $15,511 | 32.2% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 97 | 163 | $76,250 | $15,298 | 20.1% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 86 | 267 | $59,433 | $14,061 | 23.7% |
| G6013 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | Office | 2023 | 22 | 68 | $53,176 | $13,071 | 24.6% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 88 | 91 | $40,950 | $12,120 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 122 | $32,452 | $11,625 | 35.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 64 | $22,976 | $8,320 | 36.2% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Office | 2023 | 23 | 130 | $30,686 | $7,818 | 25.5% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 18 | 18 | $29,340 | $6,621 | 22.6% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 83 | 104 | $83,512 | $4,964 | 5.9% |
| 77470 | Special radiation treatment | Office | 2023 | 39 | 41 | $42,558 | $4,556 | 10.7% |
About Dr. Christopher Lee, M.D
Dr. Christopher Lee, M.D is a Radiation Oncology healthcare provider based in Spokane Valley, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043266810.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Lee, M.D has received a total of $243,434 in payments from pharmaceutical and medical device companies, with $36,742 received in 2024. These payments were reported across 319 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($156,609).
As a Medicare-enrolled provider, Lee has provided services to 11,572 Medicare beneficiaries, totaling 95,057 services with total Medicare billing of $6.2M. Data is available for 4 years (2020–2023), covering 147 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Other Specialties Radiation Oncology
- Location Spokane Valley, WA
- Active Since 05/25/2006
- Last Updated 03/24/2017
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1043266810
Products in Payments
- Xofigo (Drug) $91,604
- OPDIVO (Biological) $53,164
- PROLARIS (Device) $44,719
- KEYTRUDA (Biological) $12,503
- Prolaris (Device) $12,265
- ERBITUX (Drug) $11,648
- Nubeqa (Drug) $9,595
- BRAC CDx (Device) $3,500
- MYRISK (Device) $2,562
- ILLUCCIX (Drug) $166.86
- ALIYA SYSTEM (Device) $145.00
- OSTEOCOOL RF ABLATION (Device) $125.01
- TAGRISSO (Drug) $125.00
- IMFINZI (Drug) $124.99
- Versa HD (Device) $100.18
- Esteya (Device) $94.99
- BARRIGEL (Device) $91.50
- Monaco (Device) $88.38
- Icon (Device) $84.31
- TrueBeam (Device) $77.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Radiation Oncology Doctors in Spokane Valley
Michael Kos, Md, MD
Radiation Oncology — Payments: $6,890
Radiation Oncology $6,890
Wayne Lamoreaux, M.d, M.D
Radiation Oncology — Payments: $1,907
Radiation Oncology $1,907
Stephen Thatcher, M.d, M.D
Radiation Oncology — Payments: $612.45
Radiation Oncology $612.45
Dr. Lisa Maestas, D.o, D.O
Radiation Oncology — Payments: $605.13
Radiation Oncology $605.13
Dr. Karie-Lynn Kelly, M.d.. F.r.c.p.c, M.D.. F.R.C.P.C
Radiation Oncology — Payments: $373.79
Radiation Oncology $373.79
John Shaw, Md, MD
Radiation Oncology — Payments: $70.24
Radiation Oncology $70.24